A detailed history of Apollon Wealth Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 11,413 shares of NVS stock, worth $1.31 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,413
Previous 12,995 12.17%
Holding current value
$1.31 Million
Previous $1.26 Million 3.34%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$92.57 - $107.37 $146,445 - $169,859
-1,582 Reduced 12.17%
11,413 $1.22 Million
Q1 2024

May 02, 2024

SELL
$95.27 - $108.47 $5,239 - $5,965
-55 Reduced 0.42%
12,995 $1.26 Million
Q4 2023

Feb 06, 2024

BUY
$92.27 - $101.54 $737,237 - $811,304
7,990 Added 157.91%
13,050 $1.32 Million
Q3 2023

Nov 14, 2023

BUY
$94.73 - $105.13 $25,861 - $28,700
273 Added 5.7%
5,060 $515,000
Q2 2023

Aug 04, 2023

BUY
$92.52 - $104.91 $75,773 - $85,921
819 Added 20.64%
4,787 $483,000
Q1 2023

May 15, 2023

SELL
$80.03 - $92.81 $9,443 - $10,951
-118 Reduced 2.89%
3,968 $365,000
Q4 2022

Feb 15, 2023

SELL
$75.55 - $92.52 $113,022 - $138,409
-1,496 Reduced 26.8%
4,086 $370,000
Q3 2022

Nov 08, 2022

BUY
$74.61 - $87.26 $122,211 - $142,931
1,638 Added 41.53%
5,582 $424,000
Q2 2022

Aug 11, 2022

SELL
$80.52 - $93.75 $101,294 - $117,937
-1,258 Reduced 24.18%
3,944 $333,000
Q1 2022

May 16, 2022

SELL
$80.11 - $90.62 $410,723 - $464,608
-5,127 Reduced 49.64%
5,202 $456,000
Q4 2021

Feb 14, 2022

BUY
$79.7 - $88.13 $479,236 - $529,925
6,013 Added 139.32%
10,329 $904,000
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $352,962 - $410,624
4,316 New
4,316 $353,000
Q3 2020

Nov 03, 2020

SELL
$82.14 - $91.0 $903 - $1,001
-11 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$80.93 - $91.1 $890 - $1,002
11 New
11 $1,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $247B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Apollon Wealth Management, LLC Portfolio

Follow Apollon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.